2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abscess | D000038 | 13 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cohen-Avrahami M et al. | H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. | 2010 | Colloids Surf B Biointerfaces | pmid:20189781 |
| Amar-Yuli I and Garti N | Transitions induced by solubilized fat into reverse hexagonal mesophases. | 2005 | Colloids Surf B Biointerfaces | pmid:15921902 |
| Imberg A | On the microstructures of ethyl acetate/monoolein/water. | 2006 | Colloids Surf B Biointerfaces | pmid:17084597 |
| Garti N et al. | Lipolysis and structure controlled drug release from reversed hexagonal mesophase. | 2012 | Colloids Surf B Biointerfaces | pmid:22341515 |
| Hirano S et al. | Continuous monitoring of phospholipid vesicle hydrolysis by phospholipase D (PLD) reveals differences in hydrolysis by PLDs from 2 Streptomyces species. | 2012 | Colloids Surf B Biointerfaces | pmid:22391322 |
| Murgia S et al. | Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. | 2015 | Colloids Surf B Biointerfaces | pmid:25829131 |
| Kim JC et al. | Monoolein cubic phases containing hydrogen peroxide. | 2004 | Colloids Surf B Biointerfaces | pmid:15276632 |
| Leesajakul W et al. | Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma. | 2004 | Colloids Surf B Biointerfaces | pmid:15261065 |
| Ericsson EM et al. | Glycerol monooleate-blood interactions. | 2009 | Colloids Surf B Biointerfaces | pmid:18996684 |
| Mishraki T et al. | Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior. | 2010 | Colloids Surf B Biointerfaces | pmid:19748240 |